The global Renal Cell Carcinoma Therapy Devices market was valued at US$ 856 million in 2023 and is anticipated to reach US$ 1899.8 million by 2030, witnessing a CAGR of 12.4% during the forecast period 2024-2030.

Renal Cell Carcinoma Therapy Devices Market

Renal cell carcinoma (RCC) is increasing in incidence and one third of newly diagnosed cases already are metastatic. The metastatic spread of solid tumors renders RCC incurable by surgical resection and consequently more difficult to treat. New molecular-targeted therapies have played a pivotal role in RCC treatment.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Renal Cell Carcinoma Therapy Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Cell Carcinoma Therapy Devices.

Report Scope

The Renal Cell Carcinoma Therapy Devices market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Renal Cell Carcinoma Therapy Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Renal Cell Carcinoma Therapy Devices companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Renal Cell Carcinoma Therapy Devices Market Report

Report Metric	Details
Report Name	Renal Cell Carcinoma Therapy Devices Market
Accounted market size in 2023	US$ 856 million
Forecasted market size in 2030	US$ 1899.8 million
CAGR	12.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Directed Energy-based Therapy Devices Drug/Fluid Delivery and Infusion Therapy Devices
Segment by Application	Hospital Clinic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AngioDynamics, Inc., Boston Scientific Corporation (Galil Medical, Inc.), IceCure Medical, HealthTronics, Inc., HistoSonics, Inc., Integra LifeSciences Holdings Corporation, Medtronic plc, Monteris Medical, Inc., Novocure GmbH, Varian Medical Systems, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Renal Cell Carcinoma Therapy Devices companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Renal Cell Carcinoma Therapy Devices Market growing?

Ans: The Renal Cell Carcinoma Therapy Devices Market witnessing a CAGR of 12.4% during the forecast period 2024-2030.

What is the Renal Cell Carcinoma Therapy Devices Market size in 2030?

Ans: The Renal Cell Carcinoma Therapy Devices Market size in 2030 will be US$ 1899.8 million.

Who are the main players in the Renal Cell Carcinoma Therapy Devices Market report?

Ans: The main players in the Renal Cell Carcinoma Therapy Devices Market are AngioDynamics, Inc., Boston Scientific Corporation (Galil Medical, Inc.), IceCure Medical, HealthTronics, Inc., HistoSonics, Inc., Integra LifeSciences Holdings Corporation, Medtronic plc, Monteris Medical, Inc., Novocure GmbH, Varian Medical Systems, Inc.

What are the Application segmentation covered in the Renal Cell Carcinoma Therapy Devices Market report?

Ans: The Applications covered in the Renal Cell Carcinoma Therapy Devices Market report are Hospital, Clinic

What are the Type segmentation covered in the Renal Cell Carcinoma Therapy Devices Market report?

Ans: The Types covered in the Renal Cell Carcinoma Therapy Devices Market report are Directed Energy-based Therapy Devices, Drug/Fluid Delivery and Infusion Therapy Devices

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Renal Cell Carcinoma Therapy Devices Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Directed Energy-based Therapy Devices

1.2.3 Drug/Fluid Delivery and Infusion Therapy Devices

1.3 Market by Application

1.3.1 Global Renal Cell Carcinoma Therapy Devices Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Renal Cell Carcinoma Therapy Devices Market Perspective (2019-2030)

2.2 Renal Cell Carcinoma Therapy Devices Growth Trends by Region

2.2.1 Global Renal Cell Carcinoma Therapy Devices Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Renal Cell Carcinoma Therapy Devices Historic Market Size by Region (2019-2024)

2.2.3 Renal Cell Carcinoma Therapy Devices Forecasted Market Size by Region (2025-2030)

2.3 Renal Cell Carcinoma Therapy Devices Market Dynamics

2.3.1 Renal Cell Carcinoma Therapy Devices Industry Trends

2.3.2 Renal Cell Carcinoma Therapy Devices Market Drivers

2.3.3 Renal Cell Carcinoma Therapy Devices Market Challenges

2.3.4 Renal Cell Carcinoma Therapy Devices Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Renal Cell Carcinoma Therapy Devices Players by Revenue

3.1.1 Global Top Renal Cell Carcinoma Therapy Devices Players by Revenue (2019-2024)

3.1.2 Global Renal Cell Carcinoma Therapy Devices Revenue Market Share by Players (2019-2024)

3.2 Global Renal Cell Carcinoma Therapy Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Renal Cell Carcinoma Therapy Devices Revenue

3.4 Global Renal Cell Carcinoma Therapy Devices Market Concentration Ratio

3.4.1 Global Renal Cell Carcinoma Therapy Devices Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Renal Cell Carcinoma Therapy Devices Revenue in 2023

3.5 Renal Cell Carcinoma Therapy Devices Key Players Head office and Area Served

3.6 Key Players Renal Cell Carcinoma Therapy Devices Product Solution and Service

3.7 Date of Enter into Renal Cell Carcinoma Therapy Devices Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Renal Cell Carcinoma Therapy Devices Breakdown Data by Type

4.1 Global Renal Cell Carcinoma Therapy Devices Historic Market Size by Type (2019-2024)

4.2 Global Renal Cell Carcinoma Therapy Devices Forecasted Market Size by Type (2025-2030)

5 Renal Cell Carcinoma Therapy Devices Breakdown Data by Application

5.1 Global Renal Cell Carcinoma Therapy Devices Historic Market Size by Application (2019-2024)

5.2 Global Renal Cell Carcinoma Therapy Devices Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Renal Cell Carcinoma Therapy Devices Market Size (2019-2030)

6.2 North America Renal Cell Carcinoma Therapy Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Renal Cell Carcinoma Therapy Devices Market Size by Country (2019-2024)

6.4 North America Renal Cell Carcinoma Therapy Devices Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Renal Cell Carcinoma Therapy Devices Market Size (2019-2030)

7.2 Europe Renal Cell Carcinoma Therapy Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Renal Cell Carcinoma Therapy Devices Market Size by Country (2019-2024)

7.4 Europe Renal Cell Carcinoma Therapy Devices Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Renal Cell Carcinoma Therapy Devices Market Size (2019-2030)

8.2 Asia-Pacific Renal Cell Carcinoma Therapy Devices Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Renal Cell Carcinoma Therapy Devices Market Size by Region (2019-2024)

8.4 Asia-Pacific Renal Cell Carcinoma Therapy Devices Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Renal Cell Carcinoma Therapy Devices Market Size (2019-2030)

9.2 Latin America Renal Cell Carcinoma Therapy Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Renal Cell Carcinoma Therapy Devices Market Size by Country (2019-2024)

9.4 Latin America Renal Cell Carcinoma Therapy Devices Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Renal Cell Carcinoma Therapy Devices Market Size (2019-2030)

10.2 Middle East & Africa Renal Cell Carcinoma Therapy Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Renal Cell Carcinoma Therapy Devices Market Size by Country (2019-2024)

10.4 Middle East & Africa Renal Cell Carcinoma Therapy Devices Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AngioDynamics, Inc.

11.1.1 AngioDynamics, Inc. Company Detail

11.1.2 AngioDynamics, Inc. Business Overview

11.1.3 AngioDynamics, Inc. Renal Cell Carcinoma Therapy Devices Introduction

11.1.4 AngioDynamics, Inc. Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

11.1.5 AngioDynamics, Inc. Recent Development

11.2 Boston Scientific Corporation (Galil Medical, Inc.)

11.2.1 Boston Scientific Corporation (Galil Medical, Inc.) Company Detail

11.2.2 Boston Scientific Corporation (Galil Medical, Inc.) Business Overview

11.2.3 Boston Scientific Corporation (Galil Medical, Inc.) Renal Cell Carcinoma Therapy Devices Introduction

11.2.4 Boston Scientific Corporation (Galil Medical, Inc.) Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

11.2.5 Boston Scientific Corporation (Galil Medical, Inc.) Recent Development

11.3 IceCure Medical

11.3.1 IceCure Medical Company Detail

11.3.2 IceCure Medical Business Overview

11.3.3 IceCure Medical Renal Cell Carcinoma Therapy Devices Introduction

11.3.4 IceCure Medical Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

11.3.5 IceCure Medical Recent Development

11.4 HealthTronics, Inc.

11.4.1 HealthTronics, Inc. Company Detail

11.4.2 HealthTronics, Inc. Business Overview

11.4.3 HealthTronics, Inc. Renal Cell Carcinoma Therapy Devices Introduction

11.4.4 HealthTronics, Inc. Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

11.4.5 HealthTronics, Inc. Recent Development

11.5 HistoSonics, Inc.

11.5.1 HistoSonics, Inc. Company Detail

11.5.2 HistoSonics, Inc. Business Overview

11.5.3 HistoSonics, Inc. Renal Cell Carcinoma Therapy Devices Introduction

11.5.4 HistoSonics, Inc. Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

11.5.5 HistoSonics, Inc. Recent Development

11.6 Integra LifeSciences Holdings Corporation

11.6.1 Integra LifeSciences Holdings Corporation Company Detail

11.6.2 Integra LifeSciences Holdings Corporation Business Overview

11.6.3 Integra LifeSciences Holdings Corporation Renal Cell Carcinoma Therapy Devices Introduction

11.6.4 Integra LifeSciences Holdings Corporation Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

11.6.5 Integra LifeSciences Holdings Corporation Recent Development

11.7 Medtronic plc

11.7.1 Medtronic plc Company Detail

11.7.2 Medtronic plc Business Overview

11.7.3 Medtronic plc Renal Cell Carcinoma Therapy Devices Introduction

11.7.4 Medtronic plc Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

11.7.5 Medtronic plc Recent Development

11.8 Monteris Medical, Inc.

11.8.1 Monteris Medical, Inc. Company Detail

11.8.2 Monteris Medical, Inc. Business Overview

11.8.3 Monteris Medical, Inc. Renal Cell Carcinoma Therapy Devices Introduction

11.8.4 Monteris Medical, Inc. Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

11.8.5 Monteris Medical, Inc. Recent Development

11.9 Novocure GmbH

11.9.1 Novocure GmbH Company Detail

11.9.2 Novocure GmbH Business Overview

11.9.3 Novocure GmbH Renal Cell Carcinoma Therapy Devices Introduction

11.9.4 Novocure GmbH Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

11.9.5 Novocure GmbH Recent Development

11.10 Varian Medical Systems, Inc.

11.10.1 Varian Medical Systems, Inc. Company Detail

11.10.2 Varian Medical Systems, Inc. Business Overview

11.10.3 Varian Medical Systems, Inc. Renal Cell Carcinoma Therapy Devices Introduction

11.10.4 Varian Medical Systems, Inc. Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

11.10.5 Varian Medical Systems, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

AngioDynamics

Boston Scientific Corporation (Galil Medical, Inc.)

IceCure Medical

Healthtronics

Histosonics Inc

Integra Lifesciences Holdings Corporation

Medtronic Inc

Monteris Medical, Inc.,

Novocure

Varian Medical Systems Inc.

List of Tables

Table 1. Global Renal Cell Carcinoma Therapy Devices Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Directed Energy-based Therapy Devices

Table 3. Key Players of Drug/Fluid Delivery and Infusion Therapy Devices

Table 4. Global Renal Cell Carcinoma Therapy Devices Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Renal Cell Carcinoma Therapy Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Renal Cell Carcinoma Therapy Devices Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Renal Cell Carcinoma Therapy Devices Market Share by Region (2019-2024)

Table 8. Global Renal Cell Carcinoma Therapy Devices Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Renal Cell Carcinoma Therapy Devices Market Share by Region (2025-2030)

Table 10. Renal Cell Carcinoma Therapy Devices Market Trends

Table 11. Renal Cell Carcinoma Therapy Devices Market Drivers

Table 12. Renal Cell Carcinoma Therapy Devices Market Challenges

Table 13. Renal Cell Carcinoma Therapy Devices Market Restraints

Table 14. Global Renal Cell Carcinoma Therapy Devices Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Renal Cell Carcinoma Therapy Devices Market Share by Players (2019-2024)

Table 16. Global Top Renal Cell Carcinoma Therapy Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Cell Carcinoma Therapy Devices as of 2023)

Table 17. Ranking of Global Top Renal Cell Carcinoma Therapy Devices Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Renal Cell Carcinoma Therapy Devices Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Renal Cell Carcinoma Therapy Devices Product Solution and Service

Table 21. Date of Enter into Renal Cell Carcinoma Therapy Devices Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Renal Cell Carcinoma Therapy Devices Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Renal Cell Carcinoma Therapy Devices Revenue Market Share by Type (2019-2024)

Table 25. Global Renal Cell Carcinoma Therapy Devices Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Renal Cell Carcinoma Therapy Devices Revenue Market Share by Type (2025-2030)

Table 27. Global Renal Cell Carcinoma Therapy Devices Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Renal Cell Carcinoma Therapy Devices Revenue Market Share by Application (2019-2024)

Table 29. Global Renal Cell Carcinoma Therapy Devices Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Renal Cell Carcinoma Therapy Devices Revenue Market Share by Application (2025-2030)

Table 31. North America Renal Cell Carcinoma Therapy Devices Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Renal Cell Carcinoma Therapy Devices Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Renal Cell Carcinoma Therapy Devices Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Renal Cell Carcinoma Therapy Devices Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Renal Cell Carcinoma Therapy Devices Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Renal Cell Carcinoma Therapy Devices Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Renal Cell Carcinoma Therapy Devices Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Renal Cell Carcinoma Therapy Devices Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Renal Cell Carcinoma Therapy Devices Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Renal Cell Carcinoma Therapy Devices Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Renal Cell Carcinoma Therapy Devices Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Renal Cell Carcinoma Therapy Devices Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Renal Cell Carcinoma Therapy Devices Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Renal Cell Carcinoma Therapy Devices Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Renal Cell Carcinoma Therapy Devices Market Size by Country (2025-2030) & (US$ Million)

Table 46. AngioDynamics, Inc. Company Detail

Table 47. AngioDynamics, Inc. Business Overview

Table 48. AngioDynamics, Inc. Renal Cell Carcinoma Therapy Devices Product

Table 49. AngioDynamics, Inc. Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024) & (US$ Million)

Table 50. AngioDynamics, Inc. Recent Development

Table 51. Boston Scientific Corporation (Galil Medical, Inc.) Company Detail

Table 52. Boston Scientific Corporation (Galil Medical, Inc.) Business Overview

Table 53. Boston Scientific Corporation (Galil Medical, Inc.) Renal Cell Carcinoma Therapy Devices Product

Table 54. Boston Scientific Corporation (Galil Medical, Inc.) Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024) & (US$ Million)

Table 55. Boston Scientific Corporation (Galil Medical, Inc.) Recent Development

Table 56. IceCure Medical Company Detail

Table 57. IceCure Medical Business Overview

Table 58. IceCure Medical Renal Cell Carcinoma Therapy Devices Product

Table 59. IceCure Medical Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024) & (US$ Million)

Table 60. IceCure Medical Recent Development

Table 61. HealthTronics, Inc. Company Detail

Table 62. HealthTronics, Inc. Business Overview

Table 63. HealthTronics, Inc. Renal Cell Carcinoma Therapy Devices Product

Table 64. HealthTronics, Inc. Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024) & (US$ Million)

Table 65. HealthTronics, Inc. Recent Development

Table 66. HistoSonics, Inc. Company Detail

Table 67. HistoSonics, Inc. Business Overview

Table 68. HistoSonics, Inc. Renal Cell Carcinoma Therapy Devices Product

Table 69. HistoSonics, Inc. Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024) & (US$ Million)

Table 70. HistoSonics, Inc. Recent Development

Table 71. Integra LifeSciences Holdings Corporation Company Detail

Table 72. Integra LifeSciences Holdings Corporation Business Overview

Table 73. Integra LifeSciences Holdings Corporation Renal Cell Carcinoma Therapy Devices Product

Table 74. Integra LifeSciences Holdings Corporation Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024) & (US$ Million)

Table 75. Integra LifeSciences Holdings Corporation Recent Development

Table 76. Medtronic plc Company Detail

Table 77. Medtronic plc Business Overview

Table 78. Medtronic plc Renal Cell Carcinoma Therapy Devices Product

Table 79. Medtronic plc Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024) & (US$ Million)

Table 80. Medtronic plc Recent Development

Table 81. Monteris Medical, Inc. Company Detail

Table 82. Monteris Medical, Inc. Business Overview

Table 83. Monteris Medical, Inc. Renal Cell Carcinoma Therapy Devices Product

Table 84. Monteris Medical, Inc. Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024) & (US$ Million)

Table 85. Monteris Medical, Inc. Recent Development

Table 86. Novocure GmbH Company Detail

Table 87. Novocure GmbH Business Overview

Table 88. Novocure GmbH Renal Cell Carcinoma Therapy Devices Product

Table 89. Novocure GmbH Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024) & (US$ Million)

Table 90. Novocure GmbH Recent Development

Table 91. Varian Medical Systems, Inc. Company Detail

Table 92. Varian Medical Systems, Inc. Business Overview

Table 93. Varian Medical Systems, Inc. Renal Cell Carcinoma Therapy Devices Product

Table 94. Varian Medical Systems, Inc. Revenue in Renal Cell Carcinoma Therapy Devices Business (2019-2024) & (US$ Million)

Table 95. Varian Medical Systems, Inc. Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Renal Cell Carcinoma Therapy Devices Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Renal Cell Carcinoma Therapy Devices Market Share by Type: 2023 VS 2030

Figure 3. Directed Energy-based Therapy Devices Features

Figure 4. Drug/Fluid Delivery and Infusion Therapy Devices Features

Figure 5. Global Renal Cell Carcinoma Therapy Devices Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Renal Cell Carcinoma Therapy Devices Market Share by Application: 2023 VS 2030

Figure 7. Hospital Case Studies

Figure 8. Clinic Case Studies

Figure 9. Renal Cell Carcinoma Therapy Devices Report Years Considered

Figure 10. Global Renal Cell Carcinoma Therapy Devices Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Renal Cell Carcinoma Therapy Devices Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Renal Cell Carcinoma Therapy Devices Market Share by Region: 2023 VS 2030

Figure 13. Global Renal Cell Carcinoma Therapy Devices Market Share by Players in 2023

Figure 14. Global Top Renal Cell Carcinoma Therapy Devices Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Cell Carcinoma Therapy Devices as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Renal Cell Carcinoma Therapy Devices Revenue in 2023

Figure 16. North America Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Renal Cell Carcinoma Therapy Devices Market Share by Country (2019-2030)

Figure 18. United States Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Renal Cell Carcinoma Therapy Devices Market Share by Country (2019-2030)

Figure 22. Germany Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Renal Cell Carcinoma Therapy Devices Market Share by Region (2019-2030)

Figure 30. China Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Renal Cell Carcinoma Therapy Devices Market Share by Country (2019-2030)

Figure 38. Mexico Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Renal Cell Carcinoma Therapy Devices Market Share by Country (2019-2030)

Figure 42. Turkey Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia Renal Cell Carcinoma Therapy Devices Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. AngioDynamics, Inc. Revenue Growth Rate in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

Figure 45. Boston Scientific Corporation (Galil Medical, Inc.) Revenue Growth Rate in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

Figure 46. IceCure Medical Revenue Growth Rate in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

Figure 47. HealthTronics, Inc. Revenue Growth Rate in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

Figure 48. HistoSonics, Inc. Revenue Growth Rate in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

Figure 49. Integra LifeSciences Holdings Corporation Revenue Growth Rate in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

Figure 50. Medtronic plc Revenue Growth Rate in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

Figure 51. Monteris Medical, Inc. Revenue Growth Rate in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

Figure 52. Novocure GmbH Revenue Growth Rate in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

Figure 53. Varian Medical Systems, Inc. Revenue Growth Rate in Renal Cell Carcinoma Therapy Devices Business (2019-2024)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Cancer Pain Management Solutions Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-27G5590

Sat Jul 20 00:00:00 UTC 2024

Add to Cart

Global Cancer Biological Toxins Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-30Y9507

Fri Jul 19 00:00:00 UTC 2024

Add to Cart

Global Tumor Detection Kit Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-25O9576

Fri Jul 19 00:00:00 UTC 2024

Add to Cart

Global Antineoplastic Agents Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-23H9930

Mon Jul 08 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions